Yuzhen Gao

Dr. Yuzhen Gao


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2015 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
RTRuiyang Tao
Ruiyang Tao
SHShuxiang Hu
Shuxiang Hu
SWShouyu Wang
Shouyu Wang
XZXianju Zhou
Xianju Zhou
QZQing Zhang
Qing Zhang
YGYuzhen Gao
Yuzhen Gao
The growth arrest special 5 (GAS5) is known to be involved in various cancers. However, its expression regulation remains unclear. Polymorphisms in the promoter region of GAS5 may affect its expression and be associated with cancer susceptibility. In this research, we first evaluated the association of a 5-base pair indel polymorphism (rs145204276) in the promoter region of GAS5 with hepatocelluar carcinoma (HCC) susceptibility in Chinese populations. Logistic regression analysis showed that the deletion allele of rs145204276 significantly increased the risk of HCC in two independent case control sets (1034 HCC and 1054 controls). Further genotype-phenotype association analysis revealed that the deletion allele was markedly correlated with higher expression of GAS5 in HCC tissues. The luciferase activity analysis in an in vitro reporter gene system suggested that the deletion allele improved an increased expression of GAS5 in three hepatoma cell lines. Intriguingly, overexpression of GAS5 displayed an anti-apoptosis effect in HCC cell lines, GAS5 knockdown could partially revert this anti-apoptosis effect, suggesting that GAS5 may act as a proto-oncogene in HCC, in contrast with its inhibitory role in other cancers. Further pyrosequencing revealed that the genotypes of rs145204276 were associated with methylation status of GAS5 promoter region. Taken together, our findings provided evidence that rs145204276 may contribute to hepatocarcinogenesis by affecting methylation status of the GAS5 promoter and subsequently its transcriptional activity thus serving as a potential therapy target for HCC.

29 November 2012 in Cancer Research
Verified
Journal Article
Open access
PDF file
ZZZhansheng Zhu
Zhansheng Zhu
XGXueren Gao
Xueren Gao
YHYan He
Yan He
HZHua Zhao
Hua Zhao
QYQiang Yu
Qiang Yu
YGYuzhen Gao
Yuzhen Gao
The Prolyl hydroxylase 1 (EGLN2) is known to affect tumorigenesis by regulating the degradation of hypoxia-inducible factor. Polymorphisms in EGLN2 may facilitate cancer cell survival under hypoxic conditions and directly associate with cancer susceptibility. Here, we examined the contribution of a 4-bp insertion/deletion polymorphism (rs10680577) within the distal promoter of EGLN2 to the risk of hepatocelluar carcinoma (HCC) in Chinese populations. The contribution of rs10680577 to HCC risk was investigated in 623 HCC cases and 1,242 controls and replicated in an independent case–control study consisting of 444 HCC cases and 450 controls. Logistic regression analysis showed that the deletion allele of rs10680577 was significantly associated with increased risk for HCC occurrence in both case–control studies [OR = 1.40; 95% confidence interval (CI) = 1.18–1.66, P < 0.0001; OR = 1.49; 95% CI = 1.18–1.88, P = 0.0007]. Such positive association was more pronounced in current smokers (OR = 3.49, 95% CI = 2.24–5.45) than nonsmokers (OR = 1.24, 95% CI = 1.03–1.50; heterogeneity P = 0.0002). Genotype–phenotype correlation studies showed that the deletion allele was significantly correlated with higher expression of both EGLN2 and RERT-lncRNA [a long noncoding RNA whose sequence overlaps with Ras-related GTP-binding protein 4b (RAB4B) and EGLN2)] in vivo and in vitro. Furthermore, RERT-lncRNA expression was also significantly correlated with EGLN2 expression in vivo, consistent with in vitro gain-of-function study that showed overexpressing RERT-lncRNA upregulated EGLN2. Finally, in silico prediction suggested that the insertion allele could disrupt the structure of RERT-lncRNA. Taken together, our findings provided strong evidence for the hypothesis that rs10680577 contributes to hepatocarcinogenesis, possibly by affecting RERT-lncRNA structure and subsequently EGLN2 expression, making it a promising biomarker for early diagnosis of HCC. Cancer Res; 72(23); 6163–72. ©2012 AACR.

1 December 2011 in DNA and Cell Biology
Verified
Journal Article
Closed access
YJYuting Jiang
Yuting Jiang
SCShougong Chen
Shougong Chen
SJShasha Jia
Shasha Jia
ZZZhansheng Zhu
Zhansheng Zhu
XGXueren Gao
Xueren Gao
YGYuzhen Gao
Yuzhen Gao
The 14-bp insertion/deletion (indel) polymorphism located in the 3′ UTR of the human leukocyte antigen-G (HLA-G) gene plays a role in several autoimmune and chronic inflammatory diseases. HLA-G expression is associated with hepatocellular carcinoma (HCC) prognosis, especially in early stage, with high expression independently associated with shortened overall survival and increased tumor recurrence. In the present study, we carried out a case–control study in a Chinese population (318 cases and 599 controls) to estimate the susceptibility to HCC associated with the 14-bp indel polymorphism. Logistic regression analysis showed that the heterozygote and the homozygote 14-bp ins/ins confer a lower risk of HCC (adjusted OR = 0.75, 95% CI: 0.57–1.01, p = 0.061; OR = 0.54, 95% CI: 0.30–0.98, p = 0.031, respectively). Hepatitis B virus (HBV) stratification analysis showed that the associations were stronger in the HBV-positive population. Immunohistochemical analysis further showed that HLA-G expression in HCC tissues with 14-bp del/del genotype was more prominent than for heterozygous and 14-bp ins/ins genotype (p < 0.01). Taken together, our results suggested that the HLA-G 14-bp indel polymorphism may be a marker for genetic susceptibility to HCC in Chinese populations. Further studies from different populations with larger sample size are warranted to validate our findings.

23 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LLLimin Liu
Limin Liu
YZYing Zhao
Ying Zhao
KXKeming Xie
Keming Xie
XSXiaodong Sun
Xiaodong Sun
YGYuzhen Gao
Yuzhen Gao
ZWZufeng Wang
Zufeng Wang
Estrogen is traditionally thought to exert genomic actions through members of the nuclear receptor family. Here, we investigated the rapid nongenomic effects of 17β-estradiol (E2) on tumor necrosis factor α (TNF-α) production following lipopolysaccharide (LPS) stimulation in mouse bone marrow-derived macrophages (BMMs). We found that LPS induced TNF-α production in BMMs via phosphorylation of p38 mitogen-activated protein kinase (MAPK). E2 itself did not affect the MAPK pathway, although it attenuated LPS-induced TNF-α production through suppression of p38 MAPK activation. Recently, G protein-coupled receptor 30 (GPR30) was suggested to be a membrane estrogen receptor (mER) that can mediate nongenomic estradiol signaling. We found that BMMs expressed both intracellular estrogen receptors (iER) and mER GPR30. The specific GPR30 antagonist G-15 significantly blocked effects of estradiol on LPS-induced TNF-α production, whereas an iER antagonist did not. Moreover, E2 induced a rapid rise in intracellular free Ca2+ that was due to the influx of extracellular Ca2+ and was not inhibited by an iER antagonist or silencing of iER. Ca2+ influx was also induced by an impermeable E2 conjugated to BSA (E2-BSA), which has been used to investigate the nongenomic effects of estrogen. Consequently, Ca2+, a pivotal factor in E2-stimulated nongenomic action, was identified as the key mediator. The inhibitory effects of E2 on LPS-induced TNF-α production and p38 MAPK phosphorylation were dependent on E2-triggered Ca2+ influx because BAPTA, an intracellular Ca2+ chelator, prevented these effects. Taken together, these data indicate that E2 can down-regulate LPS-induced TNF-α production via blockade of p38 MAPK phosphorylation through the mER-mediated nongenomic Ca2+ signaling pathway in BMMs.

10 April 2012 in Gene
Verified
Journal Article
Closed access
DDDong Dong
Dong Dong
XGXueren Gao
Xueren Gao
ZZZhansheng Zhu
Zhansheng Zhu
QYQiang Yu
Qiang Yu
SBShizhong Bian
Shizhong Bian
YGYuzhen Gao
Yuzhen Gao

1 January 2017 in Forensic Science International
Verified
Journal Article
Closed access
SWShouyu Wang
Shouyu Wang
ZZZhixiang Zhang
Zhixiang Zhang
YYYa Yang
Ya Yang
CWChaoqun Wang
Chaoqun Wang
RTRuiyang Tao
Ruiyang Tao
YGYuzhen Gao
Yuzhen Gao